Azitra, Inc. (AZTR) income statement
AZTRNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.07+0.00 (0.00%)
Close on Oct 19, 2026Market cap $1.39MP/E –Yield –
Azitra, Inc. financial ratios
See a number that looks wrong?
Close on Oct 19, 2026Market cap $1.39MP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Margins | |||||
| Operating margin | – | -146,468.5% | -1,086.1% | -3,328.7% | – |
| EBITDA margin | – | -144,719.4% | -1,067.2% | -3,284.4% | – |
| Pre-tax margin | – | -119,446.1% | -1,642.3% | -3,760.7% | – |
| Net profit margin | – | -119,566.6% | -1,644.9% | -3,760.7% | – |
| Free cash flow margin | – | -135,897.5% | -1,077.1% | -2,951.6% | – |
| Returns on capital | |||||
| Return on equity | -230.7% | -208.3% | 75.8% | 43.4% | – |
| Return on assets | -176.9% | -143.8% | -183.7% | -149.0% | – |
| Return on tangible assets | -186.5% | -149.7% | -190.3% | -153.7% | – |
| Return on capital employed | -220.6% | -231.4% | -176.2% | -191.2% | – |
| NOPAT | -$8.66M | -$8.68M | -$5.89M | -$7.47M | – |
| Cash flow quality | |||||
| OCF / Sales | – | -135,783.2% | -1,073.2% | -2,940.0% | – |
| OCF / Net income | 1.02 | 1.14 | 0.65 | 0.78 | – |
| FCF / OCF | 100.2% | 100.1% | 100.4% | 100.4% | – |
| FCF / Net income | 1.03 | 1.14 | 0.65 | 0.78 | – |
| FCF / EBITDA | 103.9% | 93.9% | 100.9% | 89.9% | – |
| Unlevered free cash flow | -$11.24M | -$10.18M | -$7.26M | -$8.18M | – |
| Levered free cash flow | -$11.25M | -$10.19M | -$7.39M | -$8.38M | – |
| Efficiency | |||||
| Asset turnover | 0.00 | 0.00 | 0.11 | 0.04 | – |
| Fixed asset turnover | 0.00 | 0.01 | 0.88 | 0.34 | – |
| Receivables turnover | 0.00 | 32.19 | – | 1.62 | – |
| Days sales outstanding | – | 11.3 | – | 224.9 | – |
| CapEx to revenue | – | 114.3% | 3.9% | 11.7% | – |
| CapEx to OCF | -0.22% | -0.08% | -0.36% | -0.40% | – |
| CapEx to depreciation | 0.18 | 0.07 | 0.20 | 0.26 | – |
| Liquidity | |||||
| Current ratio | 2.83 | 3.80 | 1.58 | 1.86 | – |
| Quick ratio | 2.83 | 3.80 | 1.58 | 1.86 | – |
| Cash ratio | 1.94 | 3.31 | 1.12 | 1.57 | – |
| Working capital | $1.95M | $3.85M | $932.38K | $1.91M | – |
| Net current asset value | $1.80M | $3.57M | $333.24K | -$5.60M | – |
| Leverage | |||||
| Assets to equity | 1.32 | 1.29 | 1.76 | -0.20 | – |
| Intangibles to total assets | 6.3% | 3.3% | 4.1% | 3.1% | – |
| Interest coverage | |||||
| EBIT / Interest expense | -1,445.45 | -903.38 | -44.42 | -37.53 | – |
| EBITDA / Interest expense | -1,427.26 | -892.59 | -43.65 | -37.03 | – |
| (EBITDA − CapEx) / Interest expense | -1,430.45 | -893.30 | -43.81 | -37.16 | – |
| Per share | |||||
| Revenue per share | 0.00 | 0.0066 | 11.34 | 54.41 | – |
| EPS (basic) | -2.25 | -15.70 | -366.53 | -2,548.00 | – |
| EPS (diluted) | -2.25 | -15.70 | -366.53 | -2,548.00 | – |
| Book value per share | 0.35 | 4.98 | 48.16 | -6,946.42 | – |
| Tangible book value per share | 0.32 | 4.76 | 44.68 | -6,988.48 | – |
| Cash per share | 0.19 | 3.98 | 29.69 | 669.09 | – |
| Operating cash flow per share | -1.05 | -8.89 | -121.72 | -1,599.52 | – |
| Free cash flow per share | -1.05 | -8.90 | -122.16 | -1,605.86 | – |
| CapEx per share | 0.0023 | 0.0075 | 0.44 | 6.34 | – |
| Valuation at period end | |||||
| Market cap | $1.48M | $3.24M | $11.13M | – | – |
| Enterprise value | $82.31K | -$4.02M | $6.73M | – | – |
| P/S | – | 433x | 16.2x | – | – |
| P/B | 0.4x | 0.6x | 3.8x | – | – |
| P/TBV | 0.4x | 0.6x | 4.1x | – | – |
| P/OCF | -0.1x | -0.3x | -1.5x | – | – |
| EV/Sales | – | -535x | 9.8x | – | – |
| EV/EBITDA | – | 0.4x | – | – | – |
| EV/EBIT | – | 0.4x | – | – | – |
| EV/OCF | -0.0x | 0.4x | -0.9x | – | – |
| EV/FCF | – | 0.4x | – | – | – |
| Earnings yield | -738.1% | -276.4% | -101.4% | – | – |
| FCF yield | -757.9% | -314.1% | -66.4% | – | – |
| Cost structure | |||||
| R&D to revenue | – | 62,978.4% | 531.1% | 2,147.2% | – |
| Stock-based comp to revenue | – | 3,267.4% | 22.1% | 65.0% | – |
| Per employee | |||||
| Total employees | 13 | 12 | 10 | 10 | 10 |
| Revenue per employee | $0 | $625 | $68.60K | $28.40K | – |
| Operating profit per employee | -$843.59K | -$915.43K | -$745.05K | -$945.36K | – |
| Net income per employee | -$842.72K | -$747.29K | -$1.13M | -$1.07M | – |
| Free cash flow per employee | -$865.26K | -$849.36K | -$738.89K | -$838.26K | – |
| Growth | |||||
| Revenue 1Y growth | -100.0% | -98.9% | 141.5% | – | – |
| EBIT 1Y growth | 0.17% | -47.4% | 21.2% | – | – |
| EBITDA 1Y growth | 0.23% | -48.3% | 21.5% | – | – |
| Net income 1Y growth | -22.2% | 20.5% | -5.6% | – | – |
| Diluted EPS 1Y growth | 85.7% | 95.7% | 85.6% | – | – |
| Operating cash flow 1Y growth | -10.2% | -38.3% | 11.8% | – | – |
| Free cash flow 1Y growth | -10.4% | -37.9% | 11.9% | – | – |
| CapEx 1Y growth | 182.6% | -67.7% | -19.8% | – | – |
| CapEx 3Y CAGR | -9.9% | – | – | – | – |
| Total assets 1Y growth | -31.7% | 43.9% | -28.6% | – | – |
| Total assets 3Y CAGR | -11.2% | – | – | – | – |
| Total equity 1Y growth | -33.3% | 95.6% | 108.0% | -40.7% | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.